Rétine et glaucome : implications thérapeutiques
-
Published:2008-07
Issue:6
Volume:31
Page:2S61-2S64
-
ISSN:0181-5512
-
Container-title:Journal Français d'Ophtalmologie
-
language:fr
-
Short-container-title:Journal Français d'Ophtalmologie
Author:
Aptel F.,Denis P.
Reference33 articles.
1. Injection intravitréenne, Fiche d’information n° 65, Société Française d’Ophtalmologie. http://www.sfo.asso.fr/4-INFORMATIONS/01-Fiches-Info-P/fiche-2005-65.asp.
2. Chakravarthy U, Soubrane G, Bandello F, et al. Evolving European guidance on the medical management of neovascular age related macular degeneration. Br J Ophthalmol, 2006;90:1188-96.
3. Benz MS, Alibini TA, Holz ER, et al. Short-term course of intraocular pressure after intravitreal injection of triamcinolone acetonide. Ophthalmology, 2006;113:1174-8.
4. Frenkel RE, Mani L, Toler AR, Frenkel MP. Intraocular pressure effects of pegaptanib (Macugen) injections in patients with and without glaucoma. Am J Ophthalmol, 2007;143:1034-5.
5. Hariprasad SM, Shah GK, Blinder KJ. Short-term intraocular pressure trends following intravitreal pegaptanib (Macugen) injection. Am J Ophthalmol, 2006;141:200-1.